Bio-Works

FOKUS Patient turns international

FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.

“Everyone is screaming for talent”

Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Hor...

The TFS family is growing

TFS HealthScience is a European based CRO company with broad expertise and experiences in the biotech and pharmaceutical sector. The company is growing and the ...

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Källor: FDA:s vaccinchef tvingas bort – riktar skarp kritik mot Kennedy

Vaccinchefen vid FDA lämnar sin post och kritiserar samtidigt landets hälsominister för att ha låtit ”desinformation och lögner” styra hans tankar om vacciners säkerhet.

New diagnostic rules raise concerns

In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagno...

Björn Arvidsson: Let's build on the positive momentum

Progress needs narratives and heroes, and more than ever, going into the new year feels like an opportunity for a fresh start.

Study: Chat GPT is more empathetic than doctors

The AI tool Chat GPT is not only more accurate when it comes to answering patient questions – the chatbot is also perceived as almost 10 times more empathetic t...

The pandemic caused a reshuffle among the world’s vaccine giants – here is the new top list

Fuelled by the pandemic, the power balance in the global vaccine market has completely changed in recent years, a survey from Fierce Pharma shows

Emerson

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

Pulsen på patientförbunden del 4: Ung Cancer

”Engagemang och vilja finns, det gäller bara att hitta rätt former”, säger Therese Leijon, Ung Cancer, i Life Science Swedens artikelserie Pulsen på patientförbunden.

Start-up developing ”digital twin” received award during the EIT Health Summit

A biotech company, a medtech company and a company in digital health were on the podium when the EIT Health Catapult awarded its winners.

Svensk life science i gemensam uppmaning: ”EU har ett vägval att göra”

Inför att EU-kommissionen ska presentera en ny strategi för life science har fyra branschorganisationer i Sverige lämnat ett gemensamt inspel. Bland annat efter...

Amorphous materials take centre stage when Orexo develops new formulations

Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...

Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap

From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...

Sweden is heavily criticised for not ordering Covid vaccine

Valneva and the EU Commission have entered into an agreement for 1.25 million doses of the company’s Covid vaccine, but Sweden has not placed an order.

RegFile AB

Reformation eller utbildning? Så kan rovtidskrifterna stoppas

Olika försök har gjorts för att komma till rätta med rovtidskrifterna. Röster höjs för att reformera meriteringssystemet, medan andra lyfter vikten av utbildnin...

Swedish-Danish meeting at Medicon Village: “One of the most important life science congresses”

For the eleventh year, The Future of Swedish and Danish Life Science was held on Wednesday, and the event continues to function as a connecting link between the...

Pfizer’s record year – topped the $100 billion mark

In 2022 Pfizer, as the first pharmaceutical company in history, reached an annual revenue of more than 100 billion dollars, thereby surpassing Johnson & Johnson...

Regeringens utredare: Avveckla Vetenskapsrådet, Vinnova, Formas och Forte

Idag, onsdag, läggs ett förslag till regeringen som innebär att dagens struktur för forskningsfinansiering avvecklas och tre helt nya myndigheter bildas.

Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”

“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportuni...